Targeting Participants for Drug Courts Douglas B. Marlowe, J.D., Ph.D. National Association of Drug Court Professionals.

Slides:



Advertisements
Similar presentations
Criminal Justice and Behavioral Health Partnerships Review of projects recognizing the needs of and providing treatment supports to DUI offenders Nisha.
Advertisements

Integrating Risk/Needs Assessment Into Drug Court
Treatment of Substance Involved Offenders in Criminal Justice Settings – Challenges & Outcomes Igor Koutsenok, MD, MS Assistant Professor of Psychiatry,
Best Practices Standards Vol. I: An Overview. OBJECTIVES  Define Best Practices Standards  Identify the need for Best Practices Standards  Briefly.
Criminal Justice Sentencing Reform Chief Justice William Ray Price, Jr.
Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania TRI science addiction Effective Strategies for Drug-Abusing.
Evidence Best Practices & Latest Research Presented by: Dr. Cary Heck University of Wyoming National Association of Drug Court Professionals Developed.
Practical Application of the ORAS The Corrections Institute Center for Criminal Justice Research University of Cincinnati.
Community-Oriented Defense Performance Indicators A Conceptual Overview Michael Rempel Center for Court Innovation Presented at the Community-Oriented.
Drug Courts: Some Answers to Our Burning Questions NADCP May 2008 How Drug Court Practices Impact Recidivism and Costs Shannon Carey, Ph.D. August 2014.
Drug Offender Sentencing Alternative (DOSA): Treatment and Supervision
West Virginia’s Drug Courts: An Overview Division of Probation Services,
Targeting Dispositions by Risk, Need, Responsivity Modeling If / Then Decisions Douglas B. Marlowe, J.D., Ph.D. National Association of Drug Court Professionals.
Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania Effective Use of Rewards & Sanctions.
National Forum on Youth Violence Prevention April 2 & 3, Square miles 1,000,000 + people 10 th largest U.S. city 4 th Safest U.S. city.
Best Practices Research * Shannon Carey et al. (2012). What works?. Portland, OR: NPC Research. * Shannon Carey et al. (2012). What works? The 10 Key Components.
Second Chances: Housing and Services for Re-entering Prisoners National Alliance to End Homelessness Annual Conference Nikki Delgado Program Manager Corporation.
ASSESSMENTS OF JUVENILE OFFENDERS THROUGH EVIDENCE-BASED PRACTICES
Dual Diagnosis Capability in Addiction Treatment: A Comparison of Client Characteristics and Treatment Outcomes Laurel Mangrum, Ph.D. University of Texas.
Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania TRI science addiction Effective Use of Rewards & Sanctions.
Drug Court ♦The alternative to incarceration  History žHow and why the experiment evolved  Main Features of Drug Court žCooperation within the adversarial.
Evidence-Based Practices in Adult Drug Court Melissa Labriola, Ph.D. Center for Court Innovation
Key Moments in NADCP History A DULT D RUG C OURT A DULT D RUG C OURT B EST P RACTICE S TANDARDS B EST P RACTICE S TANDARDS D OUGLAS B. M ARLOWE, J.D.,
Assessment of Risk and Need
Evidence-Based Sentencing. Learning Objectives Describe the three principles of evidence- based practice and the key elements of evidence-based sentencing;
SUBSTANCE ABUSE AND REHABILITATION: WHAT YOU NEED TO KNOW Danielle EK Perkins, PhD, RN.
Mayor’s Office of Homeland Security and Public Safety Gang Reduction Program Los Angeles.
Offender Rehabilitation
2009 CSAT Dataset by Study ID Created by Chestnut Health Systems.
Working with Young Adults years old
Drunk Driving: A Strategy for Reducing Recidivism 12 th Annual Michigan Traffic Safety Summit Tuesday March 13, 2006 Bradley Finegood, MA, LLPC.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 37 Drug Abuse I: Basic Considerations.
The Iowa Delinquency Assessment Tool
Juvenile Crime Prevention Evaluation Phase 2 Interim Report Findings in Brief Juvenile Crime Prevention Evaluation Phase 2 Interim Report Findings in Brief.
By the end of this chapter, you should be able to:  LO1 Define community corrections and discuss its role in the criminal justice system  LO2 Describe.
Presented by: Cary Heck, Ph.D. University of Wyoming
Risk/Needs Assessment Within the Criminal Justice System.
Douglas B. Marlowe, J.D., Ph.D.
TREATMENT COURTS Inns of Court Presentation By John Markson & Elliott Levine October 17, 2012.
Evidence-Based Reentry Practices in a Jail Setting
North Carolina TASC NC TASC Bridging Systems for Effective Offender Care Management.
RISK AND NEED TRACKS SAMHSA 2013 Orleans Parish Drug Court Expansion Grant.
Key Moments in NADCP History B EST P RACTICES IN J UVENILE D RUG C OURTS B EST P RACTICES IN J UVENILE D RUG C OURTS D OUGLAS B. M ARLOWE, J.D., P H.D.
Assessment of Alcohol-Involved Offenders Douglas B. Marlowe, J.D., Ph.D. National Association of Drug Court Professionals Treatment Research Institute.
Suicide Risks, Clues & Preventive Measures. Suicide in the US 2 O 13.7 million children in the US have a mental health disorder O 2/3 of them are not.
What Makes Drug Courts Effective? Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania TRI science addiction.
Targeting Participants for Adult Drug Courts Douglas B. Marlowe, J.D., Ph.D. National Association of Drug Court Professionals.
Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania TRI science addiction Effective Programs for Drug Offenders.
Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania Evidence-Based Dispositions for Drug Offenders.
National Center for Youth in Custody First Things First: Risk and Needs Assessment Data to Determine Placement and Services Alternatives.
Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania TRI science addiction Targeting Dispositions by Risks &
Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania TRI science addiction Targeting Dispositions by Risks &
Brain diseases: Substance abuse and co-occurring disorders Mark Publicker, MD FASAM.
Targeting Participants for Drug Courts Douglas B. Marlowe, J.D., Ph.D. National Association of Drug Court Professionals.
Liam Ennis, Ph.D., R.Psych INTEGRATED THREAT AND RISK ASSESSMENT CENTRE/ ALBERTA LAW ENFORCEMENT RESPONSE TEAMS Using the Principles of Risk, Need, and.
Principles of Drug Abuse Treatment for Criminal Justice Populations Janelle Prueter Illinois TASC Presented to RSAT West VA Conference July 21, 2011.
Harm Reduction & Housing First 1. What is Housing First? An approach that offers permanent, affordable housing as quickly as possible for individuals.
Performance Evaluation of Drug Courts Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania TRI science addiction.
Department of Sociology & Criminal Justice Research Questions To what extent is family support related to reoffending for individuals recently released.
Juvenile Delinquency and Juvenile Justice
Promising Practices in Criminal Justice Reform
A MULTI-TRACK DUI COURT SYSTEM FOR REPEAT OFFENDERS
What works and What Doesn’t in Reducing Recidivism: Some Lessons Learned from Evaluating Correctional Programs By: Edward Latessa School of Criminal Justice.
Sarah L. Desmarais, Ph.D. North Carolina State University
Community Corrections Alternative Program
Harm Reduction: History U.K. Model Medicalization Approach Netherlands Normalization Approach Junkie bond.
Douglas B. Marlowe, J.D., Ph.D., FCPP
Evidence-Based Criminal Justice Reform
San Francisco Drug Court
Annals of Research and Knowledge (ARK)
Presentation transcript:

Targeting Participants for Drug Courts Douglas B. Marlowe, J.D., Ph.D. National Association of Drug Court Professionals

CitationInstitution(s) No. Drug Courts Crime Reduced Wilson et al. (2006) CampbellCollaborative 55 14% Latimer et al. (2006) Canada Dept. of Justice 66 9% 9% Shaffer (2010) University of Nevada 76 9% 9% Lowenkamp et al. (2005) University of Cincinnati 22 8% 8% Aos et al. (2006) Washington State Inst. for Public Policy for Public Policy 57 Mitchell et al. (2012) U.S.F., G.M.U. & Penn. State 92 12% Rempel et al. (2012) Urban Institute, CCI & RTI 23 13% Criminal Recidivism

72% - 88% 6%-9% 8% - 16% Most drug courts work Variable Effects (Carey et al., 2012; Downey & Roman, 2010; GAO, 2011; Mitchell et al., 2012; Shaffer, 2010) Some don’t work Some are harmful Let’s do the math: ~2,700 drug courts (as of 12/31/12) ~2,700 drug courts (as of 12/31/12) x.06 = 162 harmful drug courts + another 216 ineffective drug courts + another 216 ineffective drug courts

Variable Cost Benefits ~71% ~ 15% 14% 14% cost beneficial (Downey & Roman, 2010)

Variable Cost Benefits ~71% ~ 15% 14% 14% cost beneficial (Downey & Roman, 2010) Most are cost neutral

Effect Size by Risk Level Percent reduction in rearrests 5% 10%* Lowenkamp et al., 2005 Twice the reduction in rearrests in rearrests } 8% *p <.05 “Moderator analysis”

Drug Courts That Accepted Participants With Non-Drug Charges Had Nearly Twice the Reduction in Recidivism *p <.05 Non-drug charges included property, theft, prostitution and forgery offenses Carey et al. (2012)

Drug Courts That Accepted Participants With Prior Violence Had Equivalent Reductions in Recidivism p = n.s. Carey et al. (2012)

Drug Courts That Excluded Participants with Serious Mental Health Problems Had Over 50% Less Cost Savings *p <.05 Carey et al. (2012)

Avg. Benefit Per $1 invested Benefit /cost dollar ratio $2.21 $2.15 $4.13 $3.36 ~ 50% greater cost benefits } Bhati et al. (2008) “Synthetic analysis” { ~ 90% greater cost benefits

Risk Principle Not necessarily a risk for violence or dangerousnessNot necessarily a risk for violence or dangerousness Risk essentially means a difficult prognosis or lesser amenability to treatmentRisk essentially means a difficult prognosis or lesser amenability to treatment The higher the risk level, the more intensive the supervision and accountability should be; and vice versaThe higher the risk level, the more intensive the supervision and accountability should be; and vice versa Mixing risk levels is contraindicatedMixing risk levels is contraindicated (Andrews & Bonta, 2010)

Prognostic Risks Current age < 25 yearsCurrent age < 25 years Delinquent onset < 16 yearsDelinquent onset < 16 years Substance abuse onset < 14 yearsSubstance abuse onset < 14 years Prior rehabilitation failuresPrior rehabilitation failures History of violenceHistory of violence Antisocial Personality DisorderAntisocial Personality Disorder PsychopathyPsychopathy Familial history of crime or addictionFamilial history of crime or addiction Criminal or substance abuse associationsCriminal or substance abuse associations

Need Principle Clinical disorders or functional impairmentsClinical disorders or functional impairments Target criminogenic needs firstTarget criminogenic needs first The higher the need level, the more intensive the treatment or rehabilitation services should be; and vice versaThe higher the need level, the more intensive the treatment or rehabilitation services should be; and vice versa Mixing need levels is contraindicated (don’t do it!)Mixing need levels is contraindicated (don’t do it!) (Andrews & Bonta, 2010)

Substance Dependence or Addiction Substance Dependence or Addiction Criminogenic Needs

Substance Dependence or Addiction Substance Dependence or Addiction 1.Triggered binge response 2.Cravings or compulsions 3.Withdrawal symptoms

Substance Dependence or Addiction Substance Dependence or Addiction 1.Triggered binge response 2.Cravings or compulsions 3.Withdrawal symptoms } Abstinence is a distal goal Criminogenic Needs

Substance Dependence or Addiction Substance Dependence or Addiction 1.Triggered binge response 2.Cravings or compulsions 3.Withdrawal symptoms Substance Abuse } Abstinence is a distal goal Criminogenic Needs

Substance Dependence or Addiction Substance Dependence or Addiction 1.Triggered binge response 2.Cravings or compulsions 3.Withdrawal symptoms Substance Abuse } Abstinence is a distal goal Abstinence is a proximal goal } Criminogenic Needs

Substance Dependence or Addiction Substance Dependence or Addiction 1.Triggered binge response 2.Cravings or compulsions 3.Withdrawal symptoms Substance Abuse Collateral needs Collateral needs –Dual diagnosis –Serious functional impairments } Abstinence is a distal goal Abstinence is a proximal goal } Criminogenic Needs

Substance Dependence or Addiction Substance Dependence or Addiction 1.Triggered binge response 2.Cravings or compulsions 3.Withdrawal symptoms Substance Abuse Collateral needs Collateral needs –Dual diagnosis –Serious functional impairments } Abstinence is a distal goal Abstinence is a proximal goal } } Regimen compliance is proximal Criminogenic Needs

Alternative Tracks High Risk Low Risk HighNeeds(dependent) LowNeeds(abuse) Standard TrackAccountability, Treatment & Habilitation Treatment TrackTreatment&Habilitation Supervision TrackAccountability&Habilitation Diversion Track Secondary Prevention